Abbott Laboratories (ABT: Quote) announced CE Marking or Conformite Europeenne for a testosterone assay with improved sensitivity and clinical utility. The company noted that ARCHITECT 2nd Generation Testosterone Assay can accurately measure the wide range of testosterone levels seen in a number of different patient populations and clinical settings.
Testosterone assays play an important role in the diagnosis and management of many medical conditions in men, women, and children.
The company stated that the new assay runs on its fully-automated ARCHITECT family of analyzers and is available in several European countries, Asia Pacific, Latin America, Japan, Africa, Middle East, and India, pending country registration.
The ARCHITECT 2nd Generation Testosterone Assay is a chemiluminescent microparticle immunoassay for the quantitative determination of testosterone in human serum and plasma.
Click here to receive FREE breaking news email alerts for Abbott Laboratories and others in your portfolio
by RTT Staff Writer
For comments and feedback: firstname.lastname@example.org